×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Risk Management in Advanced Device Technology Development
Session Chair(s)
James Wabby, MHS
Global Head, Regulatory Affairs, Emerging Technologies and Combination Products
AbbVie, United States
This panel will discuss innovative medical products due to their contribution to advancing medical care and are thus expected to have major impact in the coming years. Risk management pertaining to future technologies will be critical as product become more patient centric.
Learning Objective : Analyze latest expectations and challenges utilizing an integrated risk management approach for combination products; Discuss the importance of an integrated risk management approach to increase product understanding earlier within the product development phase.
Speaker(s)
Panelist
Kimberly Trautman, MS
Trautman International Services, United States
Managing Director
Panelist
Donna Rycroft, BSN
AbbVie, United States
Director, Study Risk Management
Panelist
Olivia Wong, MBA
Gilead, United States
Director, Quality, Combination Products
Have an account?